Roche underscores leadership in oncology with new data in HER2 positive breast cancer and skin cancer
24 September 2012 | By
Data on 13 of its investigational and approved products will be presented at ESMO 2012...
List view / Grid view
24 September 2012 | By
Data on 13 of its investigational and approved products will be presented at ESMO 2012...
24 September 2012 | By Boehringer Ingelheim / Eli Lilly and Company
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a Positive Opinion from the European Medicines Agency’s (EMA) medicinal committee recommending expanding the therapeutic indication for the DPP-4 inhibitor Trajenta® (linagliptin). If approved by the European Commission, this will expand the indicated use of Trajenta® by…
24 September 2012 | By Roche
For the treatment of women with recurrent, platinum-sensitive ovarian cancer...
24 September 2012 | By Pfizer
For the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation...
24 September 2012 | By Novo Nordisk
Novo Nordisk has been ranked number four on the Science 2012 Top Employer list – up from ninth place last year...
24 September 2012 | By Elan Corporation
Mr. Hasler is currently a non-executive director of the Company and he will retire from the board of directors of the Company...
21 September 2012 | By Pittcon
The Registration Committee is pleased to announce that conferee registration is now open for Pittcon 2013, which will be held March 17-21, 2013...
21 September 2012 | By Daiichi Sankyo
Data from the PRASFIT-ACS study...
20 September 2012 | By Sanofi
Sanofi and TB Alliance have announced a new research collaboration agreement...
20 September 2012 | By Boehringer Ingelheim
Submission of a MAA to the EMA for approval of afatinib*...
20 September 2012 | By Amgen
A new indication for Prolia® approved...
19 September 2012 | By Citigate Dewe Rogerson
Wellington Partners announces the successful first closing of its new Wellington Partners IV Life Science Fund...
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
18 September 2012 | By Azbil BioVigilant
Azbil BioVigilant has entered into a distribution agreement with Archilex...
18 September 2012 | By kdm communications limited
Tecan understands that flexibility is crucial to making laboratory automation work for you...